Economic Considerations on the Use of Mifamurtide in the Treatment of Osteosarcoma in Spain

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1662
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mifamurtide and TAM-like Macrophages: Effect on Proliferation, Migration and Differentiation of Osteosarcoma Cells

Oncotarget
Oncology
2020English

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain

Journal of Health Economics and Outcomes Research
2018English

Progress in the Chemotherapeutic Treatment of Osteosarcoma (Review)

Oncology Letters
Cancer ResearchOncology
2018English

The Effects of Training on the Competitive Economic Advantage of Companies in Spain

Education Research International
Education
2014English

Cost Savings by the Use of Bemiparin in the Treatment of Patients With Venous Thromboembolism in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

DGI-034 Evaluation of the Efficacy and Safety of Mifamurtide in Osteogenic Sarcoma Treatment in Paediatric Patients

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Pin38 - Clinical and Economic Impact of the Treatment of Chronic Hepatitis C in Prison Inmates in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Economic Burden of Insulin-Related Hypoglycemia in Spain

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Economic and Practical Considerations in the Treatment of Oral Mucosal Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy